Li Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Li Liu has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Azhen Hu
Shenzhen Key Laboratory for Drug Addiction and Medication Safety, Department of Ultrasound, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen 518036, Guangdong, China
2 shared publicationsBingxuan Xu
Shenzhen Key Laboratory for Drug Addiction and Medication Safety, Department of Ultrasound, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen 518036, Guangdong, China
2 shared publicationsDie Hu
Shenzhen Key Laboratory for Drug Addiction and Medication Safety, Department of Ultrasound, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen 518036, Guangdong, China
2 shared publications- Tingting Zheng
Shenzhen Key Laboratory for Drug Addiction and Medication Safety, Department of Ultrasound, Institute of Ultrasonic Medicine, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center 4 , Shenzhen 518036
2 shared publications - Bing-Ling Lin
Department of Imaging, Peking University Shenzhen Hospital, Shenzhen Peking University-Hong Kong University of Science and Technology Medical Center , Shenzhen 518036 , China
1 shared publication Cao Mengmeng
1 shared publication
Latest Publications
- Open Access
- 1 January 2024
- Published by Pringma LLC in ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY
- Vol. 8 (3) , 116-123
Can Different Expertise Levels of Ultrasound Operators Accurately Screen with Handheld Ultrasound?
- 1 January 2024
- Published by Pringma LLC in ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY
- Vol. 8 (3) , 116-123
Open AccessCan Different Expertise Levels of Ultrasound Operators Accurately Screen with Handheld Ultrasound?
- Open Access
- 14 August 2023
- Published by Elsevier in Materials Today Bio
- Vol. 22, 100766
Exploiting targeted nanomedicine for surveillance, diagnosis, and treatment of hepatocellular carcinoma
- 14 August 2023
- Published by Elsevier in Materials Today Bio
- Vol. 22, 100766
Open AccessExploiting targeted nanomedicine for surveillance, diagnosis, and treatment of hepatocellular carcinoma
- 9 May 2023
- Published by Elsevier in Journal of Controlled Release
- Vol. 358, 319-332
Delivery of hydroxycamptothecin via sonoporation: An effective therapy for liver fibrosis
- 9 May 2023
- Published by Elsevier in Journal of Controlled Release
- Vol. 358, 319-332
Delivery of hydroxycamptothecin via sonoporation: An effective therapy for liver fibrosis
- Open Access
- 1 January 2022
- Published by Walter de Gruyter GmbH in Open Chemistry
- Vol. 20 (1) , 1327-1336
Ultrasonic-induced reversible blood–brain barrier opening: Safety evaluation into the cellular level
An important function of the blood–brain barrier (BBB) is to protect the central nervous system and maintain its homeostasis, but it is also a major barrier to the intervention and treatment of neurological diseases. Our study aimed at opening the BBB using a noninvasive method, focused ultrasound, screening for 16 different parameter combinations of frequency, peak voltage (Ppeak) and irradiation time. Comparing the results of hematoxylin–eosin staining, serum oxidative damage factor and TUNEL staining under various conditions, we obtained a parameter combination that did not lead to oxidative stress injury and apoptosis: 0.8 mHz + 900 mVpp + 90 s. It will be used as a safety parameter for BBB opening treatment of Parkinson’s disease in our subsequent experiments. In addition, the closing time after the BBB opening was verified in magnetic resonance imaging contrast examination and at the tissue level. It is worth mentioning that, different from previous studies, we focused on damage assessment at cellular and molecular levels.
- 1 January 2022
- Published by Walter de Gruyter GmbH in Open Chemistry
- Vol. 20 (1) , 1327-1336
Open AccessUltrasonic-induced reversible blood–brain barrier opening: Safety evaluation into the cellular level
An important function of the blood–brain barrier (BBB) is to protect the central nervous system and maintain its homeostasis, but it is also a major barrier to the intervention and treatment of neurological diseases. Our study aimed at opening the BBB using a noninvasive method, focused ultrasound, screening for 16 different parameter combinations of frequency, peak voltage (Ppeak) and irradiation time. Comparing the results of hematoxylin–eosin staining, serum oxidative damage factor and TUNEL staining under various conditions, we obtained a parameter combination that did not lead to oxidative stress injury and apoptosis: 0.8 mHz + 900 mVpp + 90 s. It will be used as a safety parameter for BBB opening treatment of Parkinson’s disease in our subsequent experiments. In addition, the closing time after the BBB opening was verified in magnetic resonance imaging contrast examination and at the tissue level. It is worth mentioning that, different from previous studies, we focused on damage assessment at cellular and molecular levels.
- Open Access
- 13 June 2020
- Published by Walter de Gruyter GmbH in Open Chemistry
- Vol. 18 (1) , 608-619
Treatment of adhesions after Achilles tendon injury using focused ultrasound with targeted bFGF plasmid-loaded cationic microbubbles
Nonviral targeting technology has become promising as a form of gene therapy for diseases and injuries, such as Achilles tendon injuries. In this study, we used avidin–biotin bridge and positive–negative charge attractions to load the intercellular adhesion molecule-1 (ICAM-1) antibody and the basic fibroblast growth factor (bFGF) plasmid onto the surface of the microbubbles. The saturated loading capacity for 1.1 × 108microbubble was 6.55 ± 0.53 µg. We established the ICAM-1 antigen microenvironment using tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells and found the targeting ability of the prepared microbubblesin vitro.In vivo, we also found that the injected targeted bFGF gene microbubbles expressed the bFGF gene better when compared with that of the control group. Furthermore, we evaluated adhesions after Achilles tendon injuries in rabbits using hematoxylin and eosin and immunohistochemical (IHC) staining methods. The collagen fibers were properly arranged in the tendon, and there was greater cellularity inside the tendon sheath and a clearer boundary between the internal and external tendon sheath than that of the control group. IHC staining showed greater ICAM-1 expression inside the tendon sheath when compared with outside the tendon sheath. In conclusion, targeted microbubbles can be a useful carrier of genes to provide gene therapy for the prevention of adhesions after tendon injury.
- 13 June 2020
- Published by Walter de Gruyter GmbH in Open Chemistry
- Vol. 18 (1) , 608-619
Open AccessTreatment of adhesions after Achilles tendon injury using focused ultrasound with targeted bFGF plasmid-loaded cationic microbubbles
Nonviral targeting technology has become promising as a form of gene therapy for diseases and injuries, such as Achilles tendon injuries. In this study, we used avidin–biotin bridge and positive–negative charge attractions to load the intercellular adhesion molecule-1 (ICAM-1) antibody and the basic fibroblast growth factor (bFGF) plasmid onto the surface of the microbubbles. The saturated loading capacity for 1.1 × 108microbubble was 6.55 ± 0.53 µg. We established the ICAM-1 antigen microenvironment using tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells and found the targeting ability of the prepared microbubblesin vitro.In vivo, we also found that the injected targeted bFGF gene microbubbles expressed the bFGF gene better when compared with that of the control group. Furthermore, we evaluated adhesions after Achilles tendon injuries in rabbits using hematoxylin and eosin and immunohistochemical (IHC) staining methods. The collagen fibers were properly arranged in the tendon, and there was greater cellularity inside the tendon sheath and a clearer boundary between the internal and external tendon sheath than that of the control group. IHC staining showed greater ICAM-1 expression inside the tendon sheath when compared with outside the tendon sheath. In conclusion, targeted microbubbles can be a useful carrier of genes to provide gene therapy for the prevention of adhesions after tendon injury.
- Open Access
- 11 April 2019
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 21 (1) , 1-9
A simplified lung ultrasound for the diagnosis of interstitial lung disease in connective tissue disease: a meta-analysis
Interstitial lung disease (ILD) is a common complication of connective tissue disease (CTD) and a leading cause of morbidity and mortality. There are various lung ultrasound (LUS) scoring systems with different lung intercostal spaces (LIS). The purpose of this meta-analysis was to find a simplified LUS method for the assessment of CTD-ILD. We systematically retrieved lung ultrasound diagnostic studies on CTD-ILD in PubMed, Embase, and Web of Science databases. Summary diagnostic accuracy, including sensitivity, specificity, and area under the curve (AUC), was analyzed. Subgroup analysis was conducted according to different LIS and diseases. The 11 studies included in this meta-analysis comprised a total of 487 patients with CTD. The pooled sensitivity and specificity of the LUS were 0.859 (95% confidence interval (CI) 0.812–0.898) and 0.839 (95% CI 0.782–0.886), respectively, illustrating its great value for CTD-ILD diagnosis. In addition, there were six methods to evaluate LIS, including 72, 65, 50, 14, 10, and all LIS. The pooled sensitivity and specificity of 14 LIS were 0.982 (95% CI 0.904–1.000) and 0.875 (95% CI 0.710–0.965), respectively. The pooled positive likelihood ratio (PLR), negative likelihood ratio (NLR), and diagnostic odd ratio (DOR) of 14 LIS were 7.297 (95% CI 6.050–17.45), 0.029 (95% CI 0.006–0.147), and 292.30 (95% CI 35.53–2403.8), respectively. Moreover, the AUC for systemic sclerosis (SSc) and rheumatoid arthritis (RA) was 0.929 and 0.981, respectively; the DOR for SSc and RA was 42.93 (95% CI 17.75–103.79) and 80.24 (95% CI 8.107–796.09), respectively. We found a modified and simplified method of LUS, by scanning 14 LIS in a short time, which had a very high sensitivity and specificity.
- 11 April 2019
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 21 (1) , 1-9
Open AccessA simplified lung ultrasound for the diagnosis of interstitial lung disease in connective tissue disease: a meta-analysis
Interstitial lung disease (ILD) is a common complication of connective tissue disease (CTD) and a leading cause of morbidity and mortality. There are various lung ultrasound (LUS) scoring systems with different lung intercostal spaces (LIS). The purpose of this meta-analysis was to find a simplified LUS method for the assessment of CTD-ILD. We systematically retrieved lung ultrasound diagnostic studies on CTD-ILD in PubMed, Embase, and Web of Science databases. Summary diagnostic accuracy, including sensitivity, specificity, and area under the curve (AUC), was analyzed. Subgroup analysis was conducted according to different LIS and diseases. The 11 studies included in this meta-analysis comprised a total of 487 patients with CTD. The pooled sensitivity and specificity of the LUS were 0.859 (95% confidence interval (CI) 0.812–0.898) and 0.839 (95% CI 0.782–0.886), respectively, illustrating its great value for CTD-ILD diagnosis. In addition, there were six methods to evaluate LIS, including 72, 65, 50, 14, 10, and all LIS. The pooled sensitivity and specificity of 14 LIS were 0.982 (95% CI 0.904–1.000) and 0.875 (95% CI 0.710–0.965), respectively. The pooled positive likelihood ratio (PLR), negative likelihood ratio (NLR), and diagnostic odd ratio (DOR) of 14 LIS were 7.297 (95% CI 6.050–17.45), 0.029 (95% CI 0.006–0.147), and 292.30 (95% CI 35.53–2403.8), respectively. Moreover, the AUC for systemic sclerosis (SSc) and rheumatoid arthritis (RA) was 0.929 and 0.981, respectively; the DOR for SSc and RA was 42.93 (95% CI 17.75–103.79) and 80.24 (95% CI 8.107–796.09), respectively. We found a modified and simplified method of LUS, by scanning 14 LIS in a short time, which had a very high sensitivity and specificity.